(Boursier.com) — Implanet a medical technology company specializing in spinal implants, announces that an error has been made regarding the results of the Combined General Meeting of June 9, 2022, announced during the publication of June 10, 2022. Resolutions 12 (delegation of authority with cancellation of the preferential subscription right and public offer), 13 and 14 (delegation of authority with cancellation of the preferential subscription right for the benefit of categories of persons meeting specific characteristics), 17th resolution (delegation of authority with cancellation of the preferential subscription for the benefit of Nice&Green) and 20th (authorization relating to the allocation of free shares) were not adopted, for lack of having obtained the majority, indicates the group.
As a result, the Nice & Green convertible bond financing line announced in the press release of June 16, 2022 “cannot be implemented”. The Company continues to examine various financing options, without excluding the convening of a new General Meeting to seek the agreement of the shareholders for the implementation of a new line of financing, adds Implanet, whose price stock exchange had been suspended this morning.
©2022 Boursier.com